 |
|
|
| |
Combination of ASK1 and ACC Inhibitors Increases Efficacy in Rodent Models of NASH
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
Jamie Bates, David Hollenback, Anna Zagorska, Grant R. Budas, John T. Liles, Henry Liu, Kathy Liu, Saritha Kusam,
Robert Brockett, David Newstrom, Igor Mikaelian, David G. Breckenridge
Gilead Sciences, Inc., Foster City, CA
References
1. Ichijo H, et al. Science 1997;275:90-4; 2. Schuster S, Feldstein AE. Nat Rev Gastroenterol Hepatol 2017;14:329-30; 3. Yamamoto E, et al.
Hypertension 2008;52:573-80; 4. Diehl AM, et al. J Hepatol 2017;66:S51-2; 5. Loomba R, et al. J Hepatol 2017;66:S671; 6. Abu-Elheiga L, et al.
Proc Natl Acad Sci USA 2005;102:12011-6; 7. Mao J, et al. Proc Natl Acad Sci USA 2006;103:8552-7; 8. Harriman G, et al. Proc Natl Acad Sci USA
2016;113:E1796-805; 9. Lawitz EJ, et al. EASL 2017, abstr LBO-002; 10. Loomba R, et al. AASLD 2017, abstr LB-9; 11. Charlton M, et al. Am J
Physiol Gastrointest Liver Physiol 2011;301:G825-34.
|
| |
|
|
|
|
|
